Common Stock, Shares, Outstanding of Hepion Pharmaceuticals, Inc. from 17 Aug 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Hepion Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 17 Aug 2012 to 31 Dec 2025.
  • Hepion Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 11,620,317, a 8250% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 11,620,317 +11,481,149 +8250% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 11,620,317 +4,661,946 +67% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 11,620,317 +5,821,191 +100% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 9,588,908 +4,115,782 +75% 31 Mar 2025 10-Q 19 May 2025 2025 Q1
Q4 2024 139,168 +42,793 +44% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 6,958,371 +3,120,082 +81% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 5,799,126 +1,960,837 +51% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 5,473,126 +1,661,644 +44% 31 Mar 2024 10-Q 21 May 2024 2024 Q1
Q4 2023 96,375 -3,715,106 -97% 31 Dec 2023 10-K 08 Apr 2025 2024 FY
Q3 2023 3,838,289 -72,391,328 -95% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 3,838,289 -72,391,328 -95% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 3,811,482 -72,418,135 -95% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 3,811,481 -72,413,773 -95% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 76,229,617 +4,363 +0.01% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 76,229,617 +4,372 +0.01% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 76,229,617 +4,372 +0.01% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 76,225,254 +44,200,101 +138% 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q3 2021 76,225,254 +67,200,101 +745% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 76,225,245 +67,200,184 +745% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 76,225,245 +70,151,123 +1155% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 32,025,153 +28,264,898 +752% 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q3 2020 9,025,153 +5,571,398 +161% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 9,025,061 +5,571,460 +161% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 6,074,122 -14,715,907 -71% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 3,760,255 +3,513,242 +1422% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 3,453,755 -12,861,385 -79% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 3,453,601 -7,238,573 -68% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 20,790,029 -64,161,183 -76% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 247,013 -9,545,484 -97% 31 Dec 2018 10-K 14 May 2020 2019 FY
Q3 2018 16,315,140 -61,854,575 -79% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 10,692,174 -65,015,174 -86% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 84,951,212 +21,243,864 +33% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 9,792,497 -52,987,170 -84% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 78,169,715 +22,577,770 +41% 30 Sep 2017 10-Q 14 Nov 2017 2018 Q1
Q2 2017 75,707,348 +43,476,107 +135% 30 Jun 2017 10-KT 26 Mar 2018 2017 FY
Q1 2017 63,707,348 +36,405,685 +133% 31 Mar 2017 10-Q 12 Apr 2017 2017 Q3
Q4 2016 62,779,667 +35,484,604 +130% 31 Dec 2016 10-Q 14 Feb 2017 2017 Q2
Q3 2016 55,591,945 +33,296,882 +149% 30 Sep 2016 10-Q 14 Nov 2016 2017 Q1
Q2 2016 32,231,241 +9,954,511 +45% 30 Jun 2016 10-KT 26 Mar 2018 2017 FY
Q1 2016 27,301,663 +5,028,266 +23% 31 Mar 2016 10-Q 13 May 2016 2016 Q3
Q4 2015 27,295,063 +5,021,666 +23% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q2
Q3 2015 22,295,063 +57,666 +0.26% 30 Sep 2015 10-Q 12 Nov 2015 2016 Q1
Q2 2015 22,276,730 +3,797,451 +21% 30 Jun 2015 10-K 28 Sep 2016 2016 FY
Q1 2015 22,273,397 +13,273,397 +147% 31 Mar 2015 10-Q 14 May 2015 2015 Q3
Q4 2014 22,273,397 +13,273,397 +147% 31 Dec 2014 10-Q 12 Feb 2015 2015 Q2
Q3 2014 22,237,397 +13,237,397 +147% 30 Sep 2014 10-Q 13 Nov 2014 2015 Q1
Q2 2014 18,479,279 +9,479,279 +105% 30 Jun 2014 10-K 25 Sep 2015 2015 FY
Q1 2014 9,000,000 31 Mar 2014 10-Q 14 May 2015 2015 Q3
Q4 2013 9,000,000 31 Dec 2013 10-Q 12 Feb 2015 2015 Q2
Q3 2013 9,000,000 0 0% 30 Sep 2013 10-Q 19 Nov 2013 2014 Q1
Q2 2013 9,000,000 30 Jun 2013 10-K 29 Sep 2014 2014 FY
Q3 2012 9,000,000 17 Aug 2012 10-K 25 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.